Meet Our Newest Councilors

IPC is pleased to introduce and welcome our seven newest Councilors for 2023: Andrew Alexis, Anna López Ferrer, Maja Mockenhaupt, Lev Pavlovsky, Andreas Pinter, Abir Saraswat, and Junko Takeshita. These individuals were confirmed by the IPC Board of Directors in November. They bring a diverse and broad experience in the field of psoriasis and are passionate about working to improve care for psoriasis patients around the world. IPC Councilors serve in an advisory capacity and lend their global expertise on psoriasis research, treatment, and education to support all IPC programs, events, and initiatives. They are selected based on their overall reputation in the dermatology community, experience in clinical or investigative research in psoriasis, level of clinical expertise in patient care, and demonstrated professional interest in psoriasis. Learn more about the IPC Councilors and read their full biographies.

Andrew Alexis, MD, MPH

Weill Cornell Medical College, Cornell University

New York, New York, United States

IPC Councilor

Bio

Anna López Ferrer, MD, PhD

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

IPC Councilor

Bio

Maja Mockenhaupt , MD, PhD

University of Freiburg

Freiburg, Germany

IPC Councilor

Bio

Lev Pavlovsky, MD, PhD

Tel Aviv University

Petah-Tikva, Israel

IPC Councilor

Bio

Andreas Pinter, MD, PhD

University Hospital Frankfurt

Frankfurt, Germany

IPC Councilor

Bio

Abir Saraswat, MD

Midland Hospital and Research Center

Lucknow, India

IPC Councilor

Bio

Junko Takeshita, MD, PhD, MSCE

University of Pennsylvania

Philadelphia, Pennsylvania, United States

IPC Councilor

Bio

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

A New Genetic Clue in Psoriasis: What the ADAR1 Discovery Means

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

Also Read

advocacy

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

The International Psoriasis Council welcomes Steven Fakharzadeh, MD, PhD, and Rodrigo Garcia Salinas, MD, as new Councilors, supporting IPC’s global mission in psoriasis research and care.

Monday, July 20, 2026

Psoriasis management

What Matters Most to People with Psoriasis? IPC Members Help Shape a Global Answer

IPC Members contributed to a landmark scoping study proposing an international patient-centred outcomes set for psoriasis. Learn how this global collaboration is shaping value-based care.

Monday, June 8, 2026

Six people stand side by side in business attire, smiling at the camera. Behind them, a banner reads IPC International Council 2025 Think Tank Puerto Rico, focused on Psoriasis in Latin America, with colorful designs and sunlight filtering through curtains.

Psoriasis education

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.

Wednesday, April 29, 2026

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.

Tuesday, June 23, 2026

Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress

IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.

Monday, June 22, 2026

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Meet Our Newest Councilors

Weill Cornell Medical College, Cornell University

New York, New York, United States

IPC Councilor

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

IPC Councilor

University of Freiburg

Freiburg, Germany

IPC Councilor

Tel Aviv University

Petah-Tikva, Israel

IPC Councilor

University Hospital Frankfurt

Frankfurt, Germany

IPC Councilor

Midland Hospital and Research Center

Lucknow, India

IPC Councilor

University of Pennsylvania

Philadelphia, Pennsylvania, United States

IPC Councilor

Categories

Recent Posts

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

A New Genetic Clue in Psoriasis: What the ADAR1 Discovery Means

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

Also Read

Subscribe to the IPC Newsletter

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Thursday, June 11, 2026